Kitami, M. and Ali, M.K., 2012. Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk. Global Heart, 7(2), pp.121–128. DOI: http://doi.org/10.1016/j.gheart.2012.06.004

Kitami M, Ali MK. Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk. Global Heart. 2012;7(2):121–8. DOI: http://doi.org/10.1016/j.gheart.2012.06.004

Kitami, M., & Ali, M. K. (2012). Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk. Global Heart, 7(2), 121–128. DOI: http://doi.org/10.1016/j.gheart.2012.06.004

1. Kitami M, Ali MK. Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk. Global Heart. 2012;7(2):121-128. DOI: http://doi.org/10.1016/j.gheart.2012.06.004

Kitami M and Ali MK, ‘Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk’ (2012) 7 Global Heart 121 DOI: http://doi.org/10.1016/j.gheart.2012.06.004

Kitami, Momoko, and Mohammed K. Ali. 2012. “Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk”. Global Heart 7 (2): 121–28. DOI: http://doi.org/10.1016/j.gheart.2012.06.004

Kitami, Momoko, and Mohammed K. Ali. “Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk”. Global Heart 7, no. 2 (2012): 121–28. DOI: http://doi.org/10.1016/j.gheart.2012.06.004

Kitami, Mand M K Ali. “Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk”. Global Heart, vol. 7, no. 2, 2012, pp. 121–28. DOI: http://doi.org/10.1016/j.gheart.2012.06.004